Agrauxine interview: Biologicals are not more complicated but different

摘要

Sanjiv Rana talks with French company Agrauxine by Lesaffre’s head of marketing and development global, Ronan Kempf, to discuss the company’s plans in the biologicals sector. Sanjiv Rana (SR): What have been Agrauxine by Lesaffre’s highlights in the past year in terms of licensing deals with other companies or any acquisitions made? Ronan Kempf (RK): The most important acquisition has been of US company Advanced Biological Marketing (ABM) in 2021, which became Agrauxine by Lesaffre in North America.